Old Web
English
Sign In
Acemap
>
authorDetail
>
E. Hollville
E. Hollville
Sorafenib
Medicine
Pathology
MAPK/ERK pathway
Cancer research
3
Papers
2
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Constitutive high expression of NOXA sensitizes human embryonic stem cells for rapid cell death
2021
bioRxiv
R. Basundra
S Kapoor
E. Hollville
N. Kiapour
A. B. Lopez
N. M. Melchiorre
M. Deshmukh
Show All
Source
Cite
Save
Citations (0)
Activation of the MAP-kinase pathway in the skin of patients treated with sorafenib: Clinical and molecular characterization of skin tumors associated with the multikinase inhibitor sorafenib.
2010
Journal of Clinical Oncology
C. Mateus
J.-P. Arnault
Gorana Tomasic
E. Hollville
Ludovic Lacroix
Janine Wechsler
B. Escudier
Alain Eychène
J.C. Soria
C. Robert
Show All
Source
Cite
Save
Citations (2)
Phase I/II trial of association of sorafenib in combination with temozolomide in patients with metastatic melanoma: Looking for predictive markers of efficacy.
2010
Journal of Clinical Oncology
C. Robert
Nathalie Chaput
N. Lassau
Anne Auperin
Serge Koscielny
E. Hollville
Vladimir Lazar
Ludovic Lacroix
Jeannette Soria
C. Mateus
Show All
Source
Cite
Save
Citations (0)
1